Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study
Background Management of systemic lupus erythematosus (SLE) is largely guided by organ involvement. Serositis affects up to 46% of patients, yet its treatment is mainly empirical and extrapolated from other manifestations, and long-term outcome data remain limited. We aimed to evaluate short-term re...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2026-05-01
|
| Seri Bilgileri: | RMD Open |
| Online Erişim: | https://rmdopen.bmj.com/content/12/2/e006919.full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|